These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22642026)
1. [Lip cyanosis in dapsone therapy: should the dosage be reduced?]. Stichtenoth D MMW Fortschr Med; 2012 Apr; 154(6):32. PubMed ID: 22642026 [No Abstract] [Full Text] [Related]
2. Very late recovery of dapsone-induced methemoglobinemia. Wieringa A; Bethlehem C; Hoogendoorn M; van der Maten J; van Roon EN Clin Toxicol (Phila); 2014 Jan; 52(1):80-1. PubMed ID: 24308869 [No Abstract] [Full Text] [Related]
3. Factitious methemoglobinemia. Carr KM; Elias L; Caruana LC; Rabinowitz I Am J Hematol; 1999 Nov; 62(3):196-7. PubMed ID: 10539888 [TBL] [Abstract][Full Text] [Related]
4. Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage. Manfredi G; De Panfilis G; Zampetti M; Allegra F Br J Dermatol; 1979 Apr; 100(4):427-32. PubMed ID: 454569 [TBL] [Abstract][Full Text] [Related]
5. Agranulocytosis caused by dapsone therapy for granuloma annulare. Potter MN; Yates P; Slade R; Kennedy CT J Am Acad Dermatol; 1989 Jan; 20(1):87-8. PubMed ID: 2643642 [TBL] [Abstract][Full Text] [Related]
6. Chronic dapsone use causing methemoglobinemia with oxidative hemolysis and dyserythropoiesis. Gallardo CA; Fan BE; Lim KGE; Kuperan P Am J Hematol; 2021 Dec; 96(12):1715-1716. PubMed ID: 33524190 [No Abstract] [Full Text] [Related]
7. A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis. Hayama Y; Imanishi H; Yoshimoto N; Sugawara K; Tsuruta D Acta Dermatovenerol Croat; 2020 Dec; 28(4):249-250. PubMed ID: 33835002 [TBL] [Abstract][Full Text] [Related]
8. Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid sparing agent. Quaresma MV; Bernardes Filho F; Hezel J; Peretti MC; Kac BK; Azulay-Abulafia L An Bras Dermatol; 2015; 90(3 Suppl 1):51-4. PubMed ID: 26312673 [TBL] [Abstract][Full Text] [Related]
9. Sulfonamides and sulfones in dermatologic therapy. Bernstein JE; Lorincz AL Int J Dermatol; 1981 Mar; 20(2):81-8. PubMed ID: 7012050 [No Abstract] [Full Text] [Related]
11. An unusual cause of cyanosis in a patient with COPD. Chang YJ; Ali H; Draper A; Chua F BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23456158 [TBL] [Abstract][Full Text] [Related]
12. Dapsone-induced methhaemoglobinaemia: a source of diagnostic confusion. Craig D; Cadden IS; Gormley WP; Riley MS; Jones FG; McMullin MF Int J Clin Pract; 2000 Apr; 54(3):194-6. PubMed ID: 10829363 [TBL] [Abstract][Full Text] [Related]
13. Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam. Cohen RJ; Sachs JR; Wicker DJ; Conrad ME N Engl J Med; 1968 Nov; 279(21):1127-31. PubMed ID: 5686480 [No Abstract] [Full Text] [Related]
14. Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant. Talarico JF; Metro DG J Clin Anesth; 2005 Nov; 17(7):568-70. PubMed ID: 16297761 [TBL] [Abstract][Full Text] [Related]
15. Dapsone Induced Methaemoglobinaemia A reminder the iatrogenic causes of cyanosis. Condren J; Fitzgerald D Ir Med J; 2023 Mar; 116(3):751. PubMed ID: 37555710 [No Abstract] [Full Text] [Related]
16. [Methemoglobinemia due to Dapsone: a pediatric case report]. Paccor A; Matsuda M; Capurso C; Rizzo E; Larroca MC Arch Argent Pediatr; 2018 Aug; 116(4):e612-e615. PubMed ID: 30016042 [TBL] [Abstract][Full Text] [Related]
17. Asymptomatic methaemoglobinaemia and its implications. Chawla R; Kundra P; Bhattacharya A Acta Anaesthesiol Scand; 1998 Jul; 42(6):736-8. PubMed ID: 9689284 [TBL] [Abstract][Full Text] [Related]